Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMOS
726
ChipMOS TECHNOLOGIES
IMOS
$1.89B
| $14.4M | 0.03% |
796,226
+181,335
| +29% | +$3.58M |
|
727
Tractor Supply
TSCO
$18.7B
| $14.4M | 0.03% |
852,895
+838,275
| +5,734% | +$14.9M |
|
|
JNS
728
DELISTED
Janus Capital Group Inc
JNS
| $14.3M | 0.03% |
1,054,794
-1,391,656
| -57% | -$21.7M |
|
729
Dine Brands
DIN
$457M
| $14.3M | 0.03% |
156,239
+38,723
| +33% | +$3.78M |
|
730
Banco Bradesco
BBD
$34.3B
| $14.3M | 0.03% |
5,679,500
+4,787,760
| +537% | +$16.1M |
|
731
ResMed
RMD
$33.5B
| $14.3M | 0.03% |
+280,871
| New | +$15.1M |
|
|
CCRN
732
DELISTED
Cross Country Healthcare
CCRN
| $14.3M | 0.03% |
1,051,366
+122,737
| +13% | +$1.67M |
|
733
Acuity Brands
AYI
$10.1B
| $14.3M | 0.03% |
+81,466
| New | +$15.8M |
|
|
SGYP
734
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $14.3M | 0.03% |
2,689,859
+377,257
| +16% | +$2.92M |
|
735
Yelp
YELP
$1.29B
| $14.2M | 0.03% |
657,357
+495,460
| +306% | +$13.7M |
|
|
MDC
736
DELISTED
M.D.C. Holdings, Inc.
MDC
| $14.2M | 0.03% |
+754,968
| New | +$15.8M |
|
737
HCA Healthcare
HCA
$92.9B
| $14.2M | 0.03% |
183,512
-956,231
| -84% | -$84.7M |
|
|
WR
738
DELISTED
Westar Energy Inc
WR
| $14.2M | 0.03% |
369,007
-527,524
| -59% | -$19.5M |
|
739
Avnet
AVT
$7.08B
| $14.1M | 0.03% |
330,506
+220,116
| +199% | +$9.16M |
|
|
XLNX
740
DELISTED
Xilinx Inc
XLNX
| $14.1M | 0.03% |
332,233
-889,633
| -73% | -$37.4M |
|
741
Alaska Air
ALK
$4.64B
| $14.1M | 0.03% |
177,160
-562,179
| -76% | -$42.9M |
|
742
Novavax
NVAX
$1.46B
| $14.1M | 0.03% |
99,531
+70,556
| +244% | +$15.8M |
|
743
Elevance Health
ELV
$87.3B
| $14.1M | 0.03% |
100,431
-391,244
| -80% | -$58.8M |
|
|
SIAL
744
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $14M | 0.03% |
101,129
-113,956
| -53% | -$15.9M |
|
|
MBLY
745
DELISTED
Mobileye N.V.
MBLY
| $14M | 0.03% |
308,840
-733,604
| -70% | -$40.3M |
|
746
Puma Biotechnology
PBYI
$471M
| $14M | 0.03% |
186,343
+171,283
| +1,137% | +$16.2M |
|
747
AMN Healthcare
AMN
$1.34B
| $14M | 0.03% |
466,032
-207,678
| -31% | -$6.85M |
|
748
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $14M | 0.03% |
+700,000
| New | +$15.6M |
|
749
Smith & Nephew
SNN
$12.4B
| $13.9M | 0.03% |
398,287
+90,712
| +29% | +$3.24M |
|
750
Alexandria Real Estate Equities
ARE
$9.3B
| $13.9M | 0.03% |
164,051
+64,412
| +65% | +$5.79M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.